Actual-Use Study Awareness Of Physician Influence Urged In Poster
This article was originally published in The Tan Sheet
Physician guidance to consumers on potential Rx-to-OTC switch drugs should be considered when designing an actual-use study, Bernard Schachtel, MD, Yale University School of Medicine, et al., suggest.
You may also be interested in...
Consumers using AstraZeneca/Procter & Gamble's Prilosec 1 (omeprazole 10 mg) to prevent heartburn are likely to take the drug for longer than the 10-day limit set in proposed OTC labeling, according to agency reviewers.
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands